Medical policy
Tysabri® (Natalizumab) - Commercial Medical Benefit Drug Policy
United Healthcare medical policy 2022D0026N · Oct 14, 2025
Key facts
| Policy title | Tysabri® (Natalizumab) - Commercial Medical Benefit Drug Policy |
|---|---|
| Insurer | United Healthcare |
| Policy number | 2022D0026N |
| Policy date | Oct 14, 2025 |
| Current policy | Yes |
| ICD-10 codes | G35 |
| Insurer page | uhcprovider.com |
At a glance
- 1–9 510(k)s referenced
- None PMAs referenced
- None De Novos referenced
- None Clinical trials referenced
- 1–9 Articles referenced
- None UDI devices referenced
- None NDC products referenced
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Insurer medical policies
Insurer clinical and medical policies state when a payer covers a device, drug or procedure. Orca1 links each policy to the FDA submissions, trials and articles it cites. Policy text is not reproduced here.
Source: Health insurer clinical and medical policies (insurer as listed); cross-links by Orca1